EP3355889
DÍAMÍNÓPÝRIMIDÍN P2X3 OG P2X2/3 VIÐTAKAMIÐLAR TIL NOTA VIÐ HÓSTAMEÐFERÐ
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
23.9.2016EP published:
15.2.2023EP application number:
16852340.5
EP translation filed:
24.4.2023Grant published:
15.5.2023EPO information:
European Patent Register
Max expiry date:
22.9.2036Expiry date:
22.9.2026Next due date:
30.9.2026
Title in English:
DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULATORS FOR USE IN THE TREATMENT OF COUGHLanguage of the patent:
English
Timeline
Today
23.9.2016EP application
15.2.2023EP Publication
24.4.2023Translation submitted
15.5.2023Registration published
22.9.2026Expires
Owner
Name:
Afferent Pharmaceuticals Inc.Address:
126 East Lincoln Avenue Rahway, New Jersey 07065, US
Inventor
Name:
FORD, Anthony, P.Address:
San Mateo, California 94403, US
Name:
GLAUB, Kathleen SeredaAddress:
San Mateo, California 94403, US
Name:
KITT, Michael, M.Address:
San Mateo, California 94403, US
Name:
SMITH, StevenAddress:
San Mateo, California 94403, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201562234584 PDate:
29.9.2015Country:
US
Number:
201662336381 PDate:
13.5.2016Country:
US
Classification
Categories:
A61K 9/00, A61K 9/06, A61K 9/10, A61K 9/20, A61K 9/48, A61K 31/505, A61K 45/06, A61K 47/38, A61K 47/44, A61P 11/14, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 30.6.2023
Expires: 22.9.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 15.8.2024
Expires: 22.9.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 10.9.2025
Expires: 22.9.2026
Payer: Árnason Faktor ehf.